Condition
Alzheimer's
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 3 (1)
Trial Status
Completed1
Terminated1
Recruiting1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05655195Not ApplicableRecruiting
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
NCT02260141Not ApplicableTerminatedPrimary
Treating Alzheimer's and Dementia With D-ribose
NCT03090516Phase 2UnknownPrimary
Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease
NCT00209456Phase 3Completed
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Showing all 4 trials